Results 61 to 70 of about 5,863 (219)
Vaccines with the MF59 Adjuvant Do Not Stimulate Antibody Responses against Squalene [PDF]
Clinical and Vaccine Immunology, 2006 ABSTRACT Squalene is a naturally occurring oil which has been used in the development of vaccine adjuvants, such as the oil-in-water emulsion MF59. In past years, by use of noncontrolled and nonvalidated assays, a claim was made that antisqualene antibodies were detectable in the sera of individuals with the so-called Gulf War syndrome. Using
Giuseppe, Del Giudice +9 more
openaire +2 more sources
Scientific Reports, 2021 Infants and young children are the groups at greatest risk for severe disease resulting from Plasmodium falciparum infection. We previously demonstrated in mice that a protein vaccine composed of the chemokine macrophage inflammatory protein 3α ...
Kun Luo +3 more
doaj +1 more source
Frontiers in Immunology, 2022 As new vaccine technologies and platforms, such as nanoparticles and novel adjuvants, are developed to aid in the establishment of a universal influenza vaccine, studying traditional influenza split/subunit vaccines should not be overlooked. Commercially
Mallory L. Myers +11 more
doaj +1 more source
Advanced Science, Volume 13, Issue 6, 30 January 2026.Challenging the focus on age, this study finds pre‐existing T helper 1 cells are the key biomarker for predicting antibody response to SARS‐CoV‐2 inactivated vaccines. In both mice and humans, high responders exhibited elevated baseline T helper 1 cells, which correlated with robust humoral immunity, offering crucial guidance for improving vaccine ...
Chanyuan Ye +12 more
wiley +1 more source
Journal of the Association for Information Science and Technology, Volume 77, Issue 1, Page 133-162, January 2026.Abstract In today's digital age, misinformation propagates rapidly through digital channels, blurring the lines between truth and fiction, and challenging the foundations of trust in information sources. Although affecting all spheres of life, misinformation poses a significant threat to workers highlighting a critical intersection between ...
Ashwani Malhotra +4 more
wiley +1 more source
VaccinesMF59 and AS03 are squalene emulsion-based vaccine adjuvants with similar compositions and droplet sizes. Despite their broad use in licensed influenza vaccines, few studies compared their adjuvant effects and action mechanisms side by side.
Jayachandra Reddy Nakkala +4 more
doaj +1 more source
Fluad®-MF59®-Adjuvanted Influenza Vaccine in Older Adults
Infection & Chemotherapy, 2013 Influenza directly or indirectly contributes to the four leading causes of global mortality, at rates that are highest in older adults. As the proportion of older adults in the Korean population is greater than in most other countries, influenza prevention is a greater public health priority in Korea than elsewhere.
openaire +2 more sources
Frontiers in Immunology, 2022 We previously explored a panel of adjuvants formulated with pre-fusion RSV-F protein and found that AS02 may be a promising candidate adjuvant for developing RSV-F subunit vaccines with improved immunogenicity and desired immune response type.
Lijun Bian +21 more
doaj +1 more source
Matrix-M™ adjuvation broadens protection induced by seasonal trivalent virosomal influenza vaccine [PDF]
, 2015 Background: Influenza virus infections are responsible for significant morbidity worldwide and therefore it remains a high priority to develop more broadly protective vaccines.
Eirikur Saeland +9 more
core +3 more sources
Advanced NanoBiomed Research, Volume 5, Issue 12, December 2025.Overview of the use of silica nanoparticles in vaccines against pathogens. Different kinds of vaccines against infectious diseases are currently using solid or mesoporous silica nanoparticles in their formulation. Silica microparticles and nanoparticles (SiNPs) have been studied as vehicles for vaccines.
Noe Juvenal Mendoza‐Ramírez +3 more
wiley +1 more source